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Pauklin and Vallier show that, whereas early G1 is permissive for TGF-b-dependent endoderm
differentiation, cyclin D restricts the activity of Smad2/3 in late G1, resulting in a switch from endo-
derm to neuroectoderm potential in pluripotent stem cells. These findings provide insight into how
signaling, the cell cycle, and lineage specification are coordinated.Human embryonic stem cells (hESCs)
divide rapidly and have a characteristic
cell-cycle structure comprising short gap
phases (Singh and Dalton, 2009). Conse-
quently, hESCs spend the vast majority
of time replicating DNA in S phase and
spend only a brief amount of time in G1.
In this issue of Cell, Pauklin and Vallier
(2013) address the mechanism underpin-
ning the connection between cell-cycle
transition and when pluripotent stem cells
respond to differentiation cues.
During the initial stages of cell fate
commitment, loss of pluripotency is
associated with dramatic changes in
cell-cycle structure and in the molecular
regulation that underpins cell division.
Most notably, the G1 phase becomes
longer andmore characteristic of a typical
somatic cell. Although these general
changes in cell-cycle control were origi-
nally described in embryonal carcinoma
cells around 30 years ago, demonstrating
a mechanistic connection between the
cell cycle and pathways that regulate
differentiation has been problematic. In
1987, Mummery and colleagues pub-
lished the first report implicating a clear
connection between cell-cycle position
and the ability of a cell to sense differen-
tiation cues (Mummery et al., 1987). In
these experiments, embryonal carcinoma
cells were shown to respond to retinoic
acid signaling in G1, but not at other
stages of the cell cycle. This finding was
not initially pursued in pluripotent cells,
but developmental biologists later estab-
lished interesting connections between
G1 phase and cell fate decisions. For
example, neural progenitor cells wereshown to initiate differentiation from the
G1 phase by remodeling the cell-cycle
machinery (Salomoni and Calegari,
2010). More recently, work in hESCs has
re-established the idea that pluripotent
cells are more susceptible to differen-
tiation cues in G1 compared to other
phases of the cell cycle (Sela et al., 2012).
Progress in understanding the connec-
tion between cell-cycle events and cell
fate decisions has been hampered by
the lack of suitable tools. The landscape
has recently changed, however, with the
introduction of fluorescent ubiquitin cell-
cycle indicators (FUCCI; Sakaue-Sawano
et al., 2008). The FUCCI system allows for
real-time spatiotemporal analysis of the
cell cycle and is also compatible with
fractionation into different cell compart-
ments by fluorescence-activated cell
sorting. This system removes most of
the technical bottlenecks that restricted
the field for so long. The utility of this
approach is highlighted by a recent
publication (Coronado et al., 2013) that,
together with new work from the Vallier
laboratory, lays the foundation for greater
understanding of pluripotent stem cell
biology.
Pauklin and Vallier (2013) now nicely
exploit the power of FUCCI by attempt-
ing to explain the observations made by
Mummery and coworkers many years
ago. The authors show that hESCs,
similar to embryonal carcinoma cells,
respond to specification cues in early
G1 but remain insensitive at other cell-
cycle phases. The authors ask what
mechanism underpins the ability of cells
to sense signals in early G1, but not inCell 155, Sother cell-cycle phases, by focusing
on definitive endoderm, a germ layer
requiring TGF-b-Smad2/3 signaling for
induction. Interestingly, Smad2/3 are
shown to bind and activate endoderm
target genes in early G1 but, remarkably,
are cleared from chromatin in late G1
(Figure 1). They then ask which cell-cy-
cle-dependent activity could be respon-
sible for compartmentalizing the G1 in
terms of gene activation. Potential candi-
dates are the cyclin D family and their
catalytic partners, cyclin-dependent
kinases 4/6 (Cdk4/6), which are well-
known orchestrators of G1 progression.
This possibility is highlighted by the anti-
correlation between cyclin D levels and
Smad2/3 binding to chromatin in G1
(Figure 1). Furthermore, loss of cyclin D
activity results in loss of pluripotency
and differentiation toward endoderm.
When cyclin D is overexpressed, pluripo-
tency markers are retained, but intrigu-
ingly, neuroectoderm genes are induced
and endoderm genes are no longer acti-
vated. This is interesting because the
signaling requirements for endoderm
differentiation (TGF-b and Smad2/3)
antagonize neuroectoderm differentia-
tion. These observations begin to pro-
vide mechanistic insight into the rela-
tionship between neuroectoderm and
endoderm induction.
Pauklin and Vallier (2013) further ex-
plain their observations by showing that
cyclin D activity catalyzes the phospho-
rylation of Smad2/3 in their linker region,
resulting in their clearance from chromatin
and export from the nucleus to the cyto-
plasm. This provides a nice mechanismeptember 26, 2013 ª2013 Elsevier Inc. 13
Figure 1. Compartmentalization of Signaling Activities in the G1
Phase of Human Pluripotent Stem Cells Regulates Cell Fate
Decisions
In early G1, Smad2/3 load on endoderm target genes. This enables embryonic
stem cells to be responsive toward TGF-b signaling and to differentiate into
definitive endoderm. In late G1, Smad2/3 are phosphorylated by elevated
cyclin D-Cdk4/6 activity, cleared from chromatin, and translocated from the
nucleus into the cytoplasm, opening the door for induction of neuroectoderm
genes.to explain how Smad2/3 ac-
tivity is restricted to a narrow
window of time in the cell cy-
cle and how neuroectoderm
genes can be induced in late
G1, when TGF-b signaling is
neutralized by Cdk4/6-cyclin
D activity.
The observations are
nevertheless somewhat sur-
prising, and several key ques-
tions remain unanswered. For
example, the model indicates
that Smad2/3 binding to
chromatin is restricted to
early G1, a narrow window
of time accounting for only
10% of cells. Smad2/3
would therefore be enriched
in the cytoplasm in the vast
majority of cells because
pluripotent cells spend most
of their time in S phase. This
aspect of the model is made
even more provocative when
the role of Smad2/3 in regu-lation of pluripotency genes such as
Nanog is considered (Xu et al., 2008;
Vallier et al., 2009). It seems unlikely that
Nanog expression would be restricted to
a small percentage of cells in early G1,
raising the possibility that a subset
of Smad2/3 target genes are cyclin
D independent. If only a subset of
Smad2/3 target genes is controlled by
cyclin D, what provides the specificity?
Other levels of control are clearly at
play here because Smad2/3 do not14 Cell 155, September 26, 2013 ª2013 Elseappear to load back onto chromatin after
the loss of cyclin D activity in S phase;
otherwise, differentiation could be
induced in S, G2, and M phases, and
this is clearly not the case. This report is
a very exciting beginning to what is a
new frontier in pluripotent stem cell
biology. At last, we are beginning to see
the mechanistic foundations that link the
cell cycle to cell fate decisions in pluripo-
tent cells. More broadly, it will
be interesting to establish why G1 is avier Inc.special period for lineage
induction and whether this
general mode of cell fate
commitment applies to other
multipotent cells.
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